CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,407,000 | +11.5% | 47,759 | +23.4% | 0.00% | +100.0% |
| Q2 2023 | $1,262,000 | -1.6% | 38,700 | +6.2% | 0.00% | -50.0% |
| Q1 2023 | $1,282,000 | -62.0% | 36,424 | -50.6% | 0.00% | -50.0% |
| Q4 2022 | $3,375,000 | -39.5% | 73,660 | -35.6% | 0.00% | -42.9% |
| Q3 2022 | $5,577,000 | +78.6% | 114,305 | +43.9% | 0.01% | +75.0% |
| Q2 2022 | $3,122,000 | +65.4% | 79,458 | +54.9% | 0.00% | +300.0% |
| Q1 2022 | $1,888,000 | -9.3% | 51,302 | +12.4% | 0.00% | -50.0% |
| Q4 2021 | $2,081,000 | -4.5% | 45,647 | -25.1% | 0.00% | 0.0% |
| Q3 2021 | $2,179,000 | +47.6% | 60,963 | -18.3% | 0.00% | +100.0% |
| Q2 2021 | $1,476,000 | -15.1% | 74,599 | -0.2% | 0.00% | -50.0% |
| Q1 2021 | $1,739,000 | +19.0% | 74,759 | +6.4% | 0.00% | 0.0% |
| Q4 2020 | $1,461,000 | +3378.6% | 70,290 | +3491.7% | 0.00% | – |
| Q3 2020 | $42,000 | -8.7% | 1,957 | 0.0% | 0.00% | – |
| Q2 2020 | $46,000 | +557.1% | 1,957 | +117.4% | 0.00% | – |
| Q4 2017 | $7,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |